We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Mogamulizumab
Australian Public Assessment Report
Device/Product Name
Poteligeo
Active ingredients
Mogamulizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-00700-1-6
Submission Type
New biological entity
Decision
Approved